The 1.7m is a little concerning, with the delays it may...

The 1.7m is a little concerning, with the delays it may overstretch the budget for the planned timeframe.
This may hold back the share price in the near future as investors expect a raise.
Nevertheless, we have a Scoping Study due to be released soon.
PAC Partners onboard. Low shares on issue.

Off-topic LRS just released an off-take bidding process after releasing PEA (Scoping Study).
PAC Partners have been involved with LRS, just recently for their short-term funding requirements which was oversubscribed.

I believe if we can follow a similar path it should be beneficial for us.
The Scoping Study is very important to generate interest which can lead to a competitive bidding process. If required.
It depends on how much capital we need, that's why I'm very interested to see the low-cost option, to minimise dilution.

Paul has been very good at raising funds in difficult times and has achieved a lot with a limited budget.
I'm confident whatever the future dilution he will try his best to preserve shareholders' value.